Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$5.2 - $8.42 $974,121 - $1.58 Million
-187,331 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.57 - $10.71 $383,274 - $624,789
58,337 Added 45.22%
187,331 $1.61 Million
Q1 2021

May 18, 2021

BUY
$7.09 - $13.84 $914,567 - $1.79 Million
128,994 New
128,994 $1.4 Million

Others Institutions Holding FSTX

About F-star Therapeutics, Inc.


  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.